Real-world Lithium Intake
Recruiting · NCT07167563 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Aarhus
View the official record on ClinicalTrials.gov →Interventions studied
Lithium (LI) based on clinical indication
What this trial is about
The aim of the present study is to study compliance with lithium therapy and patterns of lithium intake among a representative group of patients with bipolar disorder in a real-world clinical setting. This will be studied via a pill box that registers the daily time when the participant took the lithium tablet out of the pill box, representing a proxy for the actual lithium intake. Participants will receive a weekly phone call asking for several aspects of lithium intake.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥18 years
- Diagnosed with bipolar disorder (ICD-10: F30-31)
- Followed at the bipolar disorder outpatient clinic at AUHP
- Treated with lithium (ATC-code: N05AN01)
- Able to give informed oral and written consent.
Exclusion criteria
- Any coercive measure in the study period including patients in forensic psychiatry.
- In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.
Where it is running
1 location listed.
- Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry - Aarhus, Denmark